These emerging medications , Tirzepatide , represent a remarkable advancement in treating type 2 diabetes and conceivably associated conditions . They all are classified as GLP-1 receptor activators , https://graysonekve713740.kylieblog.com/42074986/semaglutide-a-thorough-dive-into-incretin-agents